— Know what they know.
Not Investment Advice
Also trades as: 0HKF.L (LSE) · $vol 0M

AXSM NASDAQ

Axsome Therapeutics, Inc.
1W: +0.6% 1M: +25.3% 3M: +27.2% YTD: +30.8% 1Y: +115.6% 3Y: +203.1% 5Y: +299.9%
$235.97
+2.33 (+1.00%)
 
Weekly Expected Move ±8.7%
$188 $208 $228 $247 $267
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 70 · $12.1B mcap · 44M float · 1.64% daily turnover · Short 64% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.7 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -2084.0%  ·  5Y Avg: -237.7%
Cost Advantage
59
Intangibles
50
Switching Cost
55
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AXSM shows a Weak competitive edge (53.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -2084.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$242
Low
$271
Avg Target
$302
High
Based on 13 analysts since May 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 24Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$254.81
Analysts21
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-05 Deutsche Bank David Hoang $281 $280 -1 +21.7% $230.10
2026-05-05 Morgan Stanley $217 $242 +25 +5.2% $230.11
2026-05-05 Needham $225 $267 +42 +15.8% $230.63
2026-05-05 RBC Capital Leonid Timashev $222 $302 +80 +30.7% $231.00
2026-05-05 Robert W. Baird Brian Skorney $209 $246 +37 +10.0% $223.70
2026-05-05 H.C. Wainwright $270 $290 +20 +29.6% $223.70
2026-05-04 Oppenheimer $250 $280 +30 +25.4% $223.34
2026-05-04 Guggenheim Yatin Suneja $220 $260 +40 +14.4% $227.31
2026-05-04 Piper Sandler $223 $258 +35 +13.5% $227.26
2026-05-04 Cantor Fitzgerald Initiated $272 +19.6% $227.39
2026-05-04 Jefferies Andrew Tsai $215 $275 +60 +20.7% $227.92
2026-05-04 Deutsche Bank David Hoang Initiated $281 +23.6% $227.35
2026-05-04 H.C. Wainwright Raghuram Selvaraju $260 $270 +10 +30.7% $206.53
2026-05-01 Oppenheimer $220 $250 +30 +24.4% $201.03
2026-04-30 Morgan Stanley $207 $217 +10 +4.5% $207.75
2026-04-10 UBS $251 $259 +8 +44.5% $179.25
2026-02-24 RBC Capital $219 $222 +3 +31.9% $168.35
2026-02-24 UBS $248 $251 +3 +46.9% $170.81
2026-02-24 Morgan Stanley $204 $207 +3 +18.4% $174.76
2026-02-24 Guggenheim $205 $220 +15 +25.9% $174.76
2026-02-24 Wells Fargo $193 $202 +9 +15.6% $174.76
2026-02-23 Wolfe Research Rudy Li Initiated $230 +31.6% $174.76
2026-02-23 Truist Financial Joon Lee $190 $200 +10 +15.2% $173.55
2026-02-23 Jefferies Initiated $215 +23.6% $173.90
2026-02-19 Mizuho Securities $217 $230 +13 +24.5% $184.74
2026-01-21 RBC Capital Leonid Timashev $198 $219 +21 +18.7% $184.50
2026-01-20 H.C. Wainwright $200 $260 +60 +46.7% $177.27
2026-01-16 Piper Sandler $115 $223 +108 +28.1% $174.14
2026-01-13 Robert W. Baird $162 $209 +47 +18.8% $175.99
2026-01-13 Wells Fargo $157 $193 +36 +9.2% $176.82
2026-01-08 Morgan Stanley $196 $204 +8 +19.5% $170.69
2026-01-06 UBS Initiated $248 +41.6% $175.15
2026-01-05 Needham Ami Fadia Initiated $225 +25.9% $178.69
2026-01-05 H.C. Wainwright Raghuram Selvaraju $185 $200 +15 +11.9% $178.69
2026-01-02 Guggenheim Yatin Suneja $135 $205 +70 +14.4% $179.14
2025-12-31 Mizuho Securities Graig Suvannavejh $216 $217 +1 +18.7% $182.86
2025-12-31 Oppenheimer Jay Olson Initiated $220 +20.5% $182.64
2025-11-04 H.C. Wainwright $180 $185 +5 +38.0% $134.11
2025-11-04 RBC Capital $131 $198 +67 +48.3% $133.50
2025-11-04 Morgan Stanley $194 $196 +2 +46.5% $133.81
2025-11-04 Wells Fargo $163 $157 -6 +15.7% $135.75
2025-10-20 Morgan Stanley Sean Laaman $115 $194 +79 +51.6% $127.94
2025-09-02 Wells Fargo $140 $163 +23 +32.0% $123.47
2025-05-06 Robert W. Baird Joel Beatty $160 $162 +2 +44.4% $112.16
2025-03-27 Mizuho Securities Graig Suvannavejh $137 $216 +79 +77.4% $121.77
2025-03-03 Robert W. Baird $132 $160 +28 +25.8% $127.15
2025-02-03 Mizuho Securities Graig Suvannavejh $106 $137 +31 +27.5% $107.43
2025-02-03 Truist Financial Joon Lee $150 $190 +40 +76.9% $107.43
2025-02-03 Robert W. Baird Joel Beatty $108 $132 +24 +22.9% $107.43
2024-11-12 Guggenheim Yatin Suneja $80 $135 +55 +35.7% $99.49

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AXSM receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-06 D+ C-
2026-05-04 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

47 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
20
Growth
88
Value
23
Momentum
80
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AXSM scores highest in Safety (100/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.51
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.76
Unlikely Manipulator
Ohlson O-Score
-3.69
Bankruptcy prob: 2.4%
Low Risk
Credit Rating
BBB-
Score: 53.3/100
Trend: Stable
Earnings Quality
OCF/NI: 0.38x
Accruals: -18.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AXSM scores 6.51, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AXSM scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AXSM's score of -2.76 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AXSM's implied 2.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AXSM receives an estimated rating of BBB- (score: 53.3/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-64.16x
PEG
-1.43x
P/S
17.15x
P/B
221.32x
P/FCF
-121.92x
P/OCF
EV/EBITDA
-49.63x
EV/Revenue
12.10x
EV/EBIT
-47.30x
EV/FCF
-120.77x
Earnings Yield
-2.18%
FCF Yield
-0.82%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AXSM currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.997
NI / EBT
×
Interest Burden
1.042
EBT / EBIT
×
EBIT Margin
-0.256
EBIT / Rev
×
Asset Turnover
1.126
Rev / Assets
×
Equity Multiplier
8.659
Assets / Equity
=
ROE
-259.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AXSM's ROE of -259.2% is driven by financial leverage (equity multiplier: 8.66x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$235.97
Median 1Y
$267.69
5th Pctile
$80.54
95th Pctile
$881.50
Ann. Volatility
73.5%
Analyst Target
$254.81
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Herriot Tabuteau, M.D.
Chief Executive Officer, President and Chairman of the Board
$835,000 $5,533,554 $10,283,492
Mark Jacobson, M.A.
Chief Operating Officer
$575,000 $2,082,943 $4,208,131
Nick Pizzie, C.P.A.,
M.B.A. Chief Financial Officer
$530,000 $1,822,596 $3,730,519
Hunter Murdock, Esq.
General Counsel
$530,000 $1,497,075 $3,224,304
Ari Maizel, M.B.A.
Chief Commercial Officer
$530,000 $1,497,075 $3,188,657

CEO Pay Ratio

17:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,283,492
Avg Employee Cost (SGA/emp): $616,864
Employees: 925

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
925
+35.4% YoY
Revenue / Employee
$690,266
Rev: $638,496,000
Profit / Employee
$-198,026
NI: $-183,174,000
SGA / Employee
$616,864
Avg labor cost proxy
R&D / Employee
$198,139
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -77.7% -85.9% -2.0% -2.2% -2.3% -2.5% -3.0% -2.5% -2.9% -3.2% -1.6% -2.0% -2.1% -2.1% -2.3% -2.2% -2.0% -1.9% -2.5% -2.6% -2.59%
ROA -55.9% -61.8% -95.2% -1.0% -1.1% -1.2% -89.3% -75.7% -88.0% -96.3% -52.0% -64.4% -67.1% -67.6% -49.7% -48.1% -42.7% -39.7% -29.1% -29.9% -29.93%
ROIC 4.3% 4.7% 4.7% 5.1% 5.4% 5.7% -41.8% -34.4% -40.4% -45.0% 20.7% 26.1% 27.3% 27.4% 3.4% 3.3% 2.8% 2.6% -20.1% -20.8% -20.84%
ROCE -66.8% -73.6% -1.9% -2.1% -2.2% -2.4% -76.5% -63.0% -74.0% -82.4% -51.6% -65.1% -68.0% -68.1% -82.9% -79.9% -70.0% -65.2% -56.2% -58.3% -58.28%
Gross Margin 88.9% 88.6% 90.6% 92.0% 90.2% 88.7% 89.7% 91.6% 90.8% 91.9% 91.1% 91.9% 91.0% 93.0% 93.7% 92.3% 92.30%
Operating Margin -4.4% -2.5% -2.5% -6.7% -1.4% -1.1% -1.4% -89.7% -89.5% -59.8% -61.1% -46.9% -24.5% -27.0% -15.0% -33.1% -33.14%
Net Margin -4.7% -2.7% -2.5% -11.9% -1.4% -1.1% -1.4% -91.1% -91.0% -61.7% -63.1% -48.9% -32.0% -27.6% -14.6% -33.8% -33.76%
EBITDA Margin -4.4% -2.4% -2.4% -5.0% -1.3% -1.0% -1.3% -87.3% -87.3% -57.8% -59.4% -45.2% -28.4% -26.0% -12.6% -31.9% -31.95%
FCF Margin -13.9% -4.6% -2.3% -62.4% -61.3% -64.0% -53.8% -77.0% -57.6% -39.2% -33.3% -27.4% -24.3% -18.0% -14.6% -10.0% -10.02%
OCF Margin -13.8% -4.6% -2.3% -62.0% -61.1% -63.7% -53.6% -76.8% -57.5% -39.2% -33.3% -27.4% -24.4% -18.0% -14.6% -10.0% -9.99%
ROE 3Y Avg snapshot only -2.86%
ROE 5Y Avg snapshot only -3.80%
ROA 3Y Avg snapshot only -42.21%
ROIC Economic snapshot only -43.98%
Cash ROA snapshot only -10.25%
Cash ROIC snapshot only -10.62%
CROIC snapshot only -10.66%
NOPAT Margin snapshot only -19.59%
Pretax Margin snapshot only -26.66%
R&D / Revenue snapshot only 26.99%
SGA / Revenue snapshot only 89.63%
SBC / Revenue snapshot only 9.95%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -22.32 -9.89 -10.94 -11.27 -9.98 -11.64 -17.91 -16.91 -17.01 -16.32 -15.75 -12.76 -12.41 -13.91 -14.30 -20.48 -20.90 -26.47 -50.48 -45.96 -64.159
P/S Ratio 169.71 72.50 66.97 18.56 17.20 14.74 13.92 15.07 13.14 12.78 10.65 13.19 10.43 10.82 14.48 12.22 17.145
P/B Ratio 22.29 10.91 91.28 101.48 95.76 119.05 30.59 24.50 28.64 30.06 19.72 19.80 20.05 22.65 72.04 99.97 90.52 106.55 104.73 98.01 221.321
P/FCF -28.50 -12.39 -13.18 -13.93 -12.25 -15.77 -28.59 -29.75 -28.03 -23.02 -25.86 -19.56 -22.79 -32.63 -31.98 -48.20 -42.83 -60.13 -98.87 -121.92 -121.915
P/OCF
EV/EBITDA -22.22 -9.32 -11.25 -11.57 -10.27 -12.18 -18.50 -18.14 -18.24 -17.14 -15.89 -12.56 -12.16 -13.82 -14.62 -21.29 -22.05 -28.03 -55.05 -49.63 -49.629
EV/Revenue 165.54 71.07 64.85 17.83 16.61 14.26 13.18 14.27 12.45 12.19 10.33 12.91 10.18 10.61 14.36 12.10 12.103
EV/EBIT -22.09 -9.25 -11.15 -11.46 -10.18 -11.96 -18.05 -17.44 -17.45 -16.47 -15.39 -12.24 -11.87 -13.48 -14.20 -20.64 -21.26 -26.99 -52.42 -47.30 -47.296
EV/FCF -27.00 -11.05 -12.84 -13.61 -11.95 -15.46 -27.68 -28.57 -27.09 -22.28 -24.49 -18.53 -21.60 -31.13 -31.02 -47.17 -41.81 -58.91 -97.99 -120.77 -120.765
Earnings Yield -4.5% -10.1% -9.1% -8.9% -10.0% -8.6% -5.6% -5.9% -5.9% -6.1% -6.4% -7.8% -8.1% -7.2% -7.0% -4.9% -4.8% -3.8% -2.0% -2.2% -2.18%
FCF Yield -3.5% -8.1% -7.6% -7.2% -8.2% -6.3% -3.5% -3.4% -3.6% -4.3% -3.9% -5.1% -4.4% -3.1% -3.1% -2.1% -2.3% -1.7% -1.0% -0.8% -0.82%
Price/Tangible Book snapshot only 242.166
EV/Gross Profit snapshot only 13.070
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.85 7.85 3.75 3.75 3.75 3.75 2.54 2.54 2.54 2.54 3.63 3.63 3.63 3.63 2.11 2.11 2.11 2.11 1.55 1.55 1.555
Quick Ratio 7.85 7.85 3.75 3.75 3.75 3.75 2.50 2.50 2.50 2.50 3.52 3.52 3.52 3.52 2.04 2.04 2.04 2.04 1.48 1.48 1.481
Debt/Equity 0.44 0.44 3.18 3.18 3.18 3.18 0.86 0.86 0.86 0.86 0.98 0.98 0.98 0.98 3.38 3.38 3.38 3.38 2.73 2.73 2.733
Net Debt/Equity -1.18 -1.18 -2.35 -2.35 -2.35 -2.35 -0.97 -0.97 -0.97 -0.97 -1.05 -1.05 -1.05 -1.05 -2.15 -2.15 -2.15 -2.15 -0.92 -0.92 -0.925
Debt/Assets 0.27 0.27 0.57 0.57 0.57 0.57 0.29 0.29 0.29 0.29 0.32 0.32 0.32 0.32 0.34 0.34 0.34 0.34 0.35 0.35 0.350
Debt/EBITDA -0.46 -0.42 -0.40 -0.37 -0.35 -0.33 -0.54 -0.67 -0.57 -0.51 -0.83 -0.65 -0.62 -0.62 -0.71 -0.74 -0.84 -0.91 -1.45 -1.40 -1.397
Net Debt/EBITDA 1.24 1.13 0.30 0.27 0.26 0.25 0.61 0.75 0.64 0.57 0.89 0.70 0.67 0.67 0.45 0.47 0.54 0.58 0.49 0.47 0.473
Interest Coverage -22.30 -20.65 -21.89 -24.03 -22.27 -20.67 -24.52 -17.92 -19.91 -27.35 -35.93 -55.54 -79.61 -60.51 -42.71 -34.13 -28.04 -29.04 -26.67 -34.13 -34.125
Equity Multiplier 1.64 1.64 5.62 5.62 5.62 5.62 3.03 3.03 3.03 3.03 3.08 3.08 3.08 3.08 9.97 9.97 9.97 9.97 7.81 7.81 7.813
Cash Ratio snapshot only 0.852
Debt Service Coverage snapshot only -32.521
Cash to Debt snapshot only 1.338
FCF to Debt snapshot only -0.294
Defensive Interval snapshot only 240.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.06 0.19 0.24 0.69 0.87 1.07 0.59 0.55 0.63 0.74 0.67 0.75 0.86 0.97 1.01 1.13 1.126
Inventory Turnover 2.41 5.90 7.58 9.71 2.68 2.55 2.91 3.10 2.16 2.38 2.73 2.96 2.17 2.40 2.400
Receivables Turnover 2.65 7.67 9.68 11.85 4.08 3.79 4.40 5.11 3.26 3.65 4.18 4.74 3.48 3.87 3.865
Payables Turnover 0.00 0.00 0.00 0.00 0.07 0.22 0.20 0.49 0.63 0.81 0.66 0.63 0.71 0.76 0.59 0.65 0.75 0.81 0.69 0.76 0.762
DSO 0 0 137 48 38 31 89 96 83 71 112 100 87 77 105 94 94.4 days
DIO 0 0 152 62 48 38 136 143 126 118 169 153 134 123 168 152 152.1 days
DPO 4948 1673 1817 741 577 450 555 583 512 480 617 559 487 450 529 479 478.9 days
Cash Conversion Cycle -4948 -1673 -1528 -631 -491 -382 -330 -344 -303 -290 -336 -306 -267 -250 -256 -232 -232.4 days
Fixed Asset Turnover snapshot only 33.955
Operating Cycle snapshot only 246.5 days
Cash Velocity snapshot only 2.193
Capital Intensity snapshot only 0.974
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 19.7% 7.7% 4.4% 73.6% 59.7% 51.5% 42.5% 72.2% 69.8% 65.8% 65.5% 63.9% 63.88%
Net Income -19.9% -27.4% -26.7% -41.2% -31.9% -27.3% -43.5% -12.7% -23.0% -26.2% -27.8% -86.7% -67.3% -54.1% -20.1% 6.1% 20.0% 26.2% 36.2% 32.3% 32.33%
EPS -18.3% -26.2% -25.3% -37.9% -26.9% -15.0% -24.7% 0.7% -10.1% -11.7% -17.4% -71.5% -53.6% -50.8% -17.1% 8.9% 23.0% 29.0% 38.9% 35.4% 35.41%
FCF -26.4% -32.8% -37.9% -38.1% -37.3% -17.7% -8.3% 20.7% 8.4% -21.2% -24.3% -1.1% -50.1% 7.3% 11.8% 38.8% 28.3% 23.8% 27.2% 40.0% 39.97%
EBITDA -15.7% -22.5% -23.2% -40.5% -31.5% -26.0% -42.0% -6.1% -16.9% -24.1% -28.0% -1.0% -79.5% -60.6% -21.4% 8.2% 23.4% 28.9% 38.9% 34.1% 34.08%
Op. Income -14.9% -25.1% -25.8% -43.0% -33.4% -27.2% -44.2% -9.4% -21.1% -26.9% -28.9% -97.9% -75.9% -58.3% -21.0% 7.7% 25.1% 30.6% 39.7% 35.0% 35.02%
OCF Growth snapshot only 40.22%
Asset Growth snapshot only 21.34%
Equity Growth snapshot only 54.86%
Debt Growth snapshot only 25.05%
Shares Change snapshot only 4.76%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 2.8% 1.8% 1.3% 69.8% 69.82%
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 2.9% 1.8% 1.4% 70.7% 70.70%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 73.6% 73.6% 78.7% 78.7% 78.7% 78.7% 14.5% 14.5% 14.5% 14.5% 46.7% 46.7% 46.7% 46.7% 86.4% 86.4% 86.4% 86.4% 27.7% 27.7% 27.67%
Assets 5Y 30.6% 30.6% 18.1% 18.1% 18.1% 18.1% 56.3% 56.3% 56.3% 56.3% 1.1% 1.1% 1.1% 1.1% 20.8% 20.8% 20.8% 20.8% 30.0% 30.0% 29.95%
Equity 3Y 89.5% 89.5% 1.6% 1.6% 1.6% 1.6% -15.1% -15.1% -15.1% -15.1% 18.8% 18.8% 18.8% 18.8% 53.9% 53.9% 53.9% 53.9% -6.9% -6.9% -6.94%
Book Value 3Y 67.1% 68.2% 1.4% 1.4% 1.4% 1.4% -21.1% -19.5% -19.5% -21.4% 9.8% 9.8% 9.9% 9.5% 41.6% 42.0% 42.3% 44.9% -11.6% -11.8% -11.84%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 0.41 0.41 0.41 0.41 0.44 0.48 0.53 0.68 0.70 0.73 0.76 0.83 0.85 0.87 0.88 0.91 0.910
Earnings Stability 0.87 0.88 0.89 0.90 0.92 0.95 0.95 0.97 0.99 0.99 0.98 0.86 0.90 0.93 0.99 0.86 0.81 0.75 0.53 0.46 0.461
Margin Stability 0.99 0.99 0.99 0.99 0.99 0.98 0.99 0.99 0.989
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.92 0.89 0.89 0.84 0.87 0.89 0.83 0.95 0.91 0.90 0.89 0.50 0.50 0.50 0.92 0.98 0.92 0.90 0.86 0.87 0.871
Earnings Smoothness
ROE Trend 21.81 27.50 -7.70 -8.32 -8.83 -9.40 2.92 3.49 3.61 3.82 3.77 3.68 4.02 4.41 -3.56 -3.38 -2.68 -2.29 1.07 1.08 1.084
Gross Margin Trend 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.018
FCF Margin Trend 6.66 2.23 1.11 0.42 0.35 0.34 0.29 0.42 0.422
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.78 0.80 0.83 0.81 0.81 0.74 0.62 0.57 0.60 0.70 0.61 0.65 0.54 0.43 0.45 0.43 0.49 0.44 0.51 0.38 0.376
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.004
FCF/Net Income snapshot only 0.377
CapEx/Revenue 4.6% 0.8% 1.4% 0.4% 0.2% 0.3% 0.2% 0.2% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.04%
CapEx/Depreciation snapshot only 0.029
Accruals Ratio -0.12 -0.13 -0.16 -0.20 -0.21 -0.31 -0.34 -0.33 -0.35 -0.28 -0.20 -0.23 -0.31 -0.39 -0.27 -0.28 -0.22 -0.22 -0.14 -0.19 -0.187
Sloan Accruals snapshot only -0.085
Cash Flow Adequacy snapshot only -282.920
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.4% -0.8% -0.6% -2.1% -4.3% -13.2% -7.4% -8.0% -13.0% -7.9% -6.9% -6.9% -1.4% -0.8% -1.2% -1.2% -1.8% -1.7% -1.2% -1.2% -1.23%
Total Shareholder Return -0.4% -0.8% -0.6% -2.1% -4.3% -13.2% -7.4% -8.0% -13.0% -7.9% -6.9% -6.9% -1.4% -0.8% -1.2% -1.2% -1.8% -1.7% -1.2% -1.2% -1.23%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.01 1.01 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.997
Interest Burden (EBT/EBIT) 1.04 1.05 1.05 1.04 1.04 1.05 1.04 1.06 1.05 1.04 1.03 1.02 1.01 1.02 1.02 1.03 1.05 1.04 1.05 1.04 1.042
EBIT Margin -16.27 -5.94 -3.59 -1.02 -0.95 -0.87 -0.86 -1.17 -1.05 -0.90 -0.73 -0.63 -0.48 -0.39 -0.27 -0.26 -0.256
Asset Turnover 0.00 0.00 0.00 0.00 0.06 0.19 0.24 0.69 0.87 1.07 0.59 0.55 0.63 0.74 0.67 0.75 0.86 0.97 1.01 1.13 1.126
Equity Multiplier 1.39 1.39 2.12 2.12 2.12 2.12 3.35 3.35 3.35 3.35 3.06 3.06 3.06 3.06 4.66 4.66 4.66 4.66 8.66 8.66 8.659
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-3.02 $-3.33 $-3.45 $-3.67 $-3.84 $-3.83 $-4.31 $-3.65 $-4.22 $-4.28 $-5.05 $-6.25 $-6.49 $-6.46 $-5.92 $-5.69 $-4.99 $-4.59 $-3.62 $-3.68 $-3.68
Book Value/Share $3.03 $3.02 $0.41 $0.41 $0.40 $0.37 $2.52 $2.52 $2.51 $2.33 $4.04 $4.03 $4.01 $3.97 $1.17 $1.17 $1.15 $1.14 $1.74 $1.72 $1.07
Tangible Book/Share $3.03 $3.02 $0.41 $0.41 $0.40 $0.37 $0.91 $0.91 $0.91 $0.84 $2.65 $2.65 $2.64 $2.61 $-0.04 $-0.04 $-0.04 $-0.04 $0.71 $0.70 $0.70
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.23 $0.62 $1.15 $3.32 $4.18 $4.74 $5.72 $5.30 $6.13 $7.03 $7.95 $8.84 $10.01 $11.22 $12.61 $13.83 $13.83
FCF/Share $-2.37 $-2.66 $-2.87 $-2.97 $-3.13 $-2.83 $-2.70 $-2.07 $-2.56 $-3.04 $-3.08 $-4.08 $-3.53 $-2.75 $-2.65 $-2.42 $-2.44 $-2.02 $-1.85 $-1.39 $-1.39
OCF/Share $-2.36 $-2.65 $-2.87 $-2.97 $-3.12 $-2.82 $-2.68 $-2.06 $-2.55 $-3.02 $-3.07 $-4.07 $-3.52 $-2.75 $-2.65 $-2.42 $-2.44 $-2.02 $-1.84 $-1.38 $-1.38
Cash/Share $4.89 $4.88 $2.29 $2.26 $2.21 $2.07 $4.62 $4.61 $4.60 $4.26 $8.16 $8.15 $8.12 $8.02 $6.50 $6.45 $6.38 $6.30 $6.38 $6.31 $5.96
EBITDA/Share $-2.88 $-3.15 $-3.27 $-3.50 $-3.64 $-3.59 $-4.04 $-3.27 $-3.81 $-3.95 $-4.74 $-6.02 $-6.27 $-6.20 $-5.62 $-5.36 $-4.62 $-4.25 $-3.29 $-3.37 $-3.37
Debt/Share $1.33 $1.33 $1.32 $1.30 $1.27 $1.19 $2.18 $2.18 $2.17 $2.01 $3.94 $3.93 $3.92 $3.87 $3.98 $3.95 $3.90 $3.86 $4.77 $4.71 $4.71
Net Debt/Share $-3.56 $-3.55 $-0.97 $-0.96 $-0.94 $-0.88 $-2.44 $-2.44 $-2.43 $-2.25 $-4.22 $-4.22 $-4.20 $-4.15 $-2.52 $-2.50 $-2.48 $-2.45 $-1.61 $-1.59 $-1.59
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 6.507
Altman Z-Prime snapshot only 9.167
Piotroski F-Score 1 1 1 1 2 2 4 4 5 5 5 4 5 5 3 4 4 4 5 5 5
Beneish M-Score 28.30 26.81 -1.60 -1.66 -2.52 -2.83 -3.25 -3.26 -2.94 -3.04 -2.55 -2.76 -2.762
Ohlson O-Score snapshot only -3.685
ROIC (Greenblatt) snapshot only -78.46%
Net-Net WC snapshot only $-0.24
EVA snapshot only $-139397600.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB-
Credit Score 59.59 59.71 32.13 39.21 33.89 55.37 62.27 61.84 62.04 62.01 59.56 56.47 56.47 62.25 32.55 53.63 50.17 55.43 53.97 53.33 53.326
Credit Grade snapshot only 10
Credit Trend snapshot only -0.306
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 50
Sector Credit Rank snapshot only 46

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms